Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance.

Abstract:

:Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer deaths in the United States. The deoxynucleoside analogue gemcitabine is among the most effective therapies to treat PDAC, however, nearly all patients treated with gemcitabine either fail to respond or rapidly develop resistance. One hallmark of PDAC is a striking accumulation of stromal tissue surrounding the tumor, and this accumulation of stroma can contribute to therapy resistance. To better understand how stroma limits response to therapy, we investigated cell-extrinsic mechanisms of resistance to gemcitabine. Conditioned media from pancreatic stellate cells (PSC), as well as from other fibroblasts, protected PDAC cells from gemcitabine toxicity. The protective effect of PSC-conditioned media was mediated by secretion of deoxycytidine, but not other deoxynucleosides, through equilibrative nucleoside transporters. Deoxycytidine inhibited the processing of gemcitabine in PDAC cells, thus reducing the effect of gemcitabine and other nucleoside analogues on cancer cells. These results suggest that reducing deoxycytidine production in PSCs may increase the efficacy of nucleoside analog therapies. SIGNIFICANCE: This study provides important new insight into mechanisms that contribute to gemcitabine resistance in PDAC and suggests new avenues for improving gemcitabine efficacy.

journal_name

Cancer Res

journal_title

Cancer research

authors

Dalin S,Sullivan MR,Lau AN,Grauman-Boss B,Mueller HS,Kreidl E,Fenoglio S,Luengo A,Lees JA,Vander Heiden MG,Lauffenburger DA,Hemann MT

doi

10.1158/0008-5472.CAN-19-0960

subject

Has Abstract

pub_date

2019-11-15 00:00:00

pages

5723-5733

issue

22

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-19-0960

journal_volume

79

pub_type

杂志文章
  • Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.

    abstract::Dilution end point loss of heterozygosity (LOH) analysis, a novel approach for the analysis of LOH, was used to evaluate allelic losses with the use of 21 highly polymorphic microsatellite markers at nine chromosomal sites most frequently affected in smoking-related non-small cell lung cancers. Allelotyping was done f...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-3297

    authors: Pan H,Califano J,Ponte JF,Russo AL,Cheng KH,Thiagalingam A,Nemani P,Sidransky D,Thiagalingam S

    更新日期:2005-03-01 00:00:00

  • Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.

    abstract::Cross-coupling of active protein-1 (AP-1) and nuclear factor (NF)-kappaB has been reported. In the present study, we investigated the possibility that both of these two transcription factors might contribute to the process of tumor promoter-induced transformation. To establish a stable reporter cell system, two report...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Li JJ,Westergaard C,Ghosh P,Colburn NH

    更新日期:1997-08-15 00:00:00

  • Epigenetic silencing of the DNA repair enzyme O6-methylguanine-DNA methyltransferase in Mex- human cells.

    abstract::Regulation of the expression of the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) has been investigated in a number of human lymphoblastoid cell lines. In a number of Mex- cell lines that do not express methyltransferase activity, CpG sequences in the mgmt gene were hypomethylated with respect to met...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cairns-Smith S,Karran P

    更新日期:1992-10-01 00:00:00

  • Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.

    abstract::Glutamate-triggered signal transduction is thought to contribute widely to cancer pathogenesis. In melanoma, overexpression of the metabotropic glutamate receptor (GRM)-1 occurs frequently and its ectopic expression in melanocytes is sufficient for neoplastic transformation. Clinical evaluation of the GRM1 signaling i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1531

    authors: Wen Y,Li J,Koo J,Shin SS,Lin Y,Jeong BS,Mehnert JM,Chen S,Cohen-Sola KA,Goydos JS

    更新日期:2014-05-01 00:00:00

  • Humanized Mouse Xenograft Models: Narrowing the Tumor-Microenvironment Gap.

    abstract::Cancer research has long been hampered by the limitations of the current model systems. Both cultured cells and mouse xenografts grow in an environment highly dissimilar to that of their originating tumor, frequently resulting in promising treatments that are ultimately clinically ineffective. The development of highl...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-16-1260

    authors: Morton JJ,Bird G,Refaeli Y,Jimeno A

    更新日期:2016-11-01 00:00:00

  • Radioresistant Cervical Cancers Are Sensitive to Inhibition of Glycolysis and Redox Metabolism.

    abstract::Highly glycolytic cervical cancers largely resist treatment by cisplatin and coadministered pelvic irradiation as the present standard of care. In this study, we investigated the effects of inhibiting glycolysis and thiol redox metabolism to evaluate them as alternate treatment strategies in these cancers. In a panel ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-2367

    authors: Rashmi R,Huang X,Floberg JM,Elhammali AE,McCormick ML,Patti GJ,Spitz DR,Schwarz JK

    更新日期:2018-03-15 00:00:00

  • Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia.

    abstract::2'-Deoxycoformycin (2'-dCF), a tight-binding inhibitor of adenosine deaminase, was administered to 26 pediatric patients with acute lymphoblastic leukemia in a Phase I study. Doses ranged from 0.25 to 1.0 mg/kg given i.v. for 3 consecutive days. Common toxicity included nausea, vomiting, diarrhea, hepatocellular enzym...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Poplack DG,Sallan SE,Rivera G,Holcenberg J,Murphy SB,Blatt J,Lipton JM,Venner P,Glaubiger DL,Ungerleider R,Johns D

    更新日期:1981-09-01 00:00:00

  • Lipophilic cisplatin analogues entrapped in liposomes: role of intraliposomal drug activation in biological activity.

    abstract::cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) (NDDP), a lipophilic cisplatin analogue containing two branched leaving groups of 10 carbon atoms, is undergoing clinical evaluation in a liposomal formulation. In previous studies, NDDP entrapped in multilamellar vesicles composed of dimyristoylphosp...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Perez-Soler R,Khokhar AR

    更新日期:1992-11-15 00:00:00

  • SIRT6 promotes COX-2 expression and acts as an oncogene in skin cancer.

    abstract::SIRT6 is a SIR2 family member that regulates multiple molecular pathways involved in metabolism, genomic stability, and aging. It has been proposed previously that SIRT6 is a tumor suppressor in cancer. Here, we challenge this concept by presenting evidence that skin-specific deletion of SIRT6 in the mouse inhibits sk...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-1308

    authors: Ming M,Han W,Zhao B,Sundaresan NR,Deng CX,Gupta MP,He YY

    更新日期:2014-10-15 00:00:00

  • Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.

    abstract::Gliomas are primary brain tumors with high mortality and heterogeneous biology that is insufficiently understood. In this study, we performed a systematic analysis of the intrinsic organization of complex glioma transcriptome to gain deeper knowledge of the tumor biology. Gene coexpression relationships were explored ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-2465

    authors: Ivliev AE,'t Hoen PA,Sergeeva MG

    更新日期:2010-12-15 00:00:00

  • Effect of acrolein on phosphoramide mustard-induced sister chromatid exchanges in cultured human lymphocytes.

    abstract::Although phosphoramide mustard (PM) is generally recognized as being the most genotoxic metabolite of cyclophosphamide (CP), the contribution of acrolein to the cytogenetic toxicity of CP is unclear. Besides covalently binding to DNA, acrolein can inactivate critical proteins necessary for replicative DNA synthesis, R...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wilmer JL,Erexson GL,Kligerman AD

    更新日期:1990-08-01 00:00:00

  • Biological considerations for radioimmunotherapy.

    abstract::We have examined three methods that may be useful for improving the therapeutic efficacy of antibody-targeted radionuclides. The principal limitation of radioimmunotherapy is myelotoxicity and thrombocytopenia. These are due mainly to the length of time the radioantibody remains in the blood. The clearance time of a r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sharkey RM,Blumenthal RD,Hansen HJ,Goldenberg DM

    更新日期:1990-02-01 00:00:00

  • Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice.

    abstract::Gene-targeted mice that contain a His6-tagged mouse c-Myc cDNA, Myc(His), inserted head to head into different sites of the mouse immunoglobulin heavy-chain locus, Igh, mimic the chromosomal T(12;15)(Igh-Myc) translocation that results in the activation of Myc in the great majority of mouse plasmacytomas. Mice carryin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1222

    authors: Park SS,Shaffer AL,Kim JS,duBois W,Potter M,Staudt LM,Janz S

    更新日期:2005-09-01 00:00:00

  • Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer cells treated with topoisomerase II-interactive antitumor drugs.

    abstract::Hormone stimulation of responsive neoplasms is a potential strategy for improving the target selectivity of cancer chemotherapy. Using an alkaline DNA-unwinding technique to detect drug-induced DNA strand breakage, we have shown that estrogen stimulation of T-47D human breast cancer cells enhances induction of DNA cle...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Epstein RJ,Smith PJ

    更新日期:1988-01-15 00:00:00

  • A study of alpha1-fetoprotein levels during exposure to 3'-methyl-4-dimethylaminoazobenzene and its analogs.

    abstract::The serum concentration of alpha1-fetoprotein (alpha1F) was determined in rats following exposure to the hepatocarcinogen, 3'-methyl-4-dimethylaminoazobenzene, and its analogs. Small quantities of the carcinogen caused a rapid and significant elevation of alpha1F. Neither 2-methyl-4-dimethylaminoazobenzene nor p-amino...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Becker FF,Horland AA,Shurgin A,Sell S

    更新日期:1975-06-01 00:00:00

  • Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.

    abstract::Solid tumors contain a subset of stem-like cells that are resistant to the cytotoxic effects of chemotherapy/radiotherapy, but their susceptibility to cytolytic T lymphocyte (CTL) effector mechanisms has not been well characterized. Using a panel of early-passage human brain tumor stem/initiating cell (BTSC) lines der...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2687

    authors: Brown CE,Starr R,Martinez C,Aguilar B,D'Apuzzo M,Todorov I,Shih CC,Badie B,Hudecek M,Riddell SR,Jensen MC

    更新日期:2009-12-01 00:00:00

  • Isozymes of pyruvate kinase from human brain, meningiomas, and malignant gliomas.

    abstract::Pyruvate kinase isozymes were studied in normal brain tissue (both fetal and adult) and in meningiomas and malignant gliomas. In fetal brain five different forms could be detected by electrophoresis (K4, K3M, K2M2, KM3, and M4). In adult brain the M4-type, K3M hybrid, and K4-type are present; the M isozyme is largely ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: van Veelen CW,Verbiest H,Vlug AM,Rijksen G,Staal GE

    更新日期:1978-12-01 00:00:00

  • Partial synchronization of L1210 cells by 5-fluorouracil and its use in drug combinations.

    abstract::When L1210 cells growing logarithmically were exposed for 8 hr to a nonlethal dose of 5-fluorouracil (FU) (0.25 microgram/ml), the percentage of cells in S phase increased from 74.9% in the asynchronous culture to 93% in the FU-treated culture. This resulted in increased cell-kill by S-phase-specific inhibitors [1-bet...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bhuyan BK,Blowers CL,Neil GL,Bono VH,Day KJ

    更新日期:1977-09-01 00:00:00

  • Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay.

    abstract::The ability of the in vitro sister chromatid exchange (SCE) assay to predict in vivo tumor drug sensitivity was investigated using a spontaneous hepatocarcinoma in C3Hf/Kam mice and 3 chemotherapeutic agents: melphalan; cis-platinum; and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). For hepatocarcinoma cells grown in m...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tofilon PJ,Basic I,Milas L

    更新日期:1985-05-01 00:00:00

  • Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers.

    abstract::The existence of two subgroups of BRCA1-associated breast cancer (BC) families has been recently posited: the first with highly proliferating tumors, and the second composed of cases with a low proliferation rate. Our aim was to test whether the proliferation rate of BRCA1-associated breast cancers was affected by the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sobol H,Stoppa-Lyonnet D,Bressac-de-Paillerets B,Peyrat JP,Kerangueven F,Janin N,Noguchi T,Eisinger F,Guinebretiere JM,Jacquemier J,Birnbaum D

    更新日期:1996-07-15 00:00:00

  • Reduced toxicity and enhanced antitumor effects in mice of the ionophoric drug valinomycin when incorporated in liposomes.

    abstract::Valinomycin (NSC 122023) is a cyclic depsipeptide antibiotic with potassium selective ionophoric activity. This drug has been reported to display antitumor effects but its utilization has been limited by its extreme toxicity. Here we report that the incorporation of valinomycin into multilamellar liposomes composed of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Daoud SS,Juliano RL

    更新日期:1986-11-01 00:00:00

  • A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

    abstract::We have previously reported that rodent tumor cell lines secrete a potent vascular permeability factor with a molecular weight of 34,000-42,000 (Senger et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Wash. DC), 219: 983-985, 1983). This tumor-secreted vas...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Senger DR,Perruzzi CA,Feder J,Dvorak HF

    更新日期:1986-11-01 00:00:00

  • Development and evaluation of the specificity of a rat monoclonal anti-idiotype antibody, WN, to an anti-B-cell lymphoma monoclonal antibody, LL2.

    abstract::Anti-idiotype monoclonal antibodies (Mabs) to mLL2, an anti-B-cell lymphoma and CD22-specific murine IgG2a-kappa Mab, were generated by hybridoma technology from splenocytes of Copenhagen rats immunized with mLL2 F(ab')2. Mab WN, an IgG2a-kappa, was selected based on its specific binding to mLL2 and not other IgG isot...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Losman MJ,Leung SO,Shih LB,Shevitz J,Shukla R,Haraga L,Goldenberg DM,Hansen HJ

    更新日期:1995-12-01 00:00:00

  • Effects of prostacyclin on tumor cell-induced platelet aggregation.

    abstract::Prostacyclin has been evaluated for its ability to inhibit tumor cell-induced platelet aggregation (TCIPA) induced by several rodent tumor lines: B16a (melanoma); 3LL (carcinoma); 15091A (adenocarcinoma); and W256 (carcinosarcoma). Aggregation of human platelets by all four lines was inhibited by prostaglandin I2 (PGI...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Menter DG,Onoda JM,Taylor JD,Honn KV

    更新日期:1984-02-01 00:00:00

  • Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.

    abstract::Clonal variants of mouse epidermal JB6 cells that are genetically susceptible (P+) or resistant (P-) to tumor promoter-induced neoplastic transformation exhibit differential activator protein-1 (AP-1) response. Transactivation of AP-1 appears to be necessary but not sufficient to promote transformation in JB6 cells. I...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hsu TC,Nair R,Tulsian P,Camalier CE,Hegamyer GA,Young MR,Colburn NH

    更新日期:2001-05-15 00:00:00

  • The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.

    abstract::Glycogen synthase kinase 3beta (GSK3beta) is a multifunctional serine/threonine kinase. We showed that the expression of GSK3beta was drastically down-regulated in human cutaneous squamous cell carcinomas and basal cell carcinomas. Due to its negative regulation of many oncogenic proteins, we hypothesized that GSK3bet...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-4665

    authors: Ma C,Wang J,Gao Y,Gao TW,Chen G,Bower KA,Odetallah M,Ding M,Ke Z,Luo J

    更新日期:2007-08-15 00:00:00

  • Substrate-specific deoxycytidine kinase deficiency in 1-beta-D-arabinofuranosylcytosine-resistant leukemic cells.

    abstract::In this study we describe the establishment of a leukemic cell line (BNML-CL/ara-C), originating from the 1-beta-D-arabinofuranosylcytosine (ara-C)-resistant brown Norway rat myelocytic leukemia model (BNML/ara-C), that retains the in vivo generated ara-C resistance. Its biological and biochemical characteristics have...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Richel DJ,Colly LP,Arkesteijn GJ,Arentsen-Honders MW,Kerster MG,ter Riet PM,Willemze R

    更新日期:1990-10-15 00:00:00

  • Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo.

    abstract::A phenolic amine compound, 4-S-cysteaminylphenol (4-S-CAP), is a potent depigmenting agent. To develop more efficacious antimelanoma agents, we synthesized four homologues of 4-S-CAP: N-acetyl-4-S-CAP (N-Ac-4-S-CAP), alpha-methyl-4-S-CAP, 4-S-homo-CAP, and N,N'-dimethyl-4-S-CAP. We tested these five compounds in mice ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Alena F,Jimbow K,Ito S

    更新日期:1990-06-15 00:00:00

  • Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.

    abstract::Increasing evidence argues that the success of an anticancer treatment may rely on immunoadjuvant side effects including the induction of immunogenic tumor cell death. Based on the assumption that this death mechanism is a similar prerequisite for the efficacy of an active immunotherapy using killed tumor cells, we ex...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-1825

    authors: Zappasodi R,Pupa SM,Ghedini GC,Bongarzone I,Magni M,Cabras AD,Colombo MP,Carlo-Stella C,Gianni AM,Di Nicola M

    更新日期:2010-11-15 00:00:00

  • Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells.

    abstract::The effects of vascular endothelial growth factor-A (VEGF-A/VEGF) and its receptors on endothelial cells function have been studied extensively, but their effects on tumor cells are less well defined. Studies of human colorectal cancer cells where the VEGF gene has been deleted suggest an intracellular role of VEGF as...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-1605

    authors: Bhattacharya R,Ye XC,Wang R,Ling X,McManus M,Fan F,Boulbes D,Ellis LM

    更新日期:2016-05-15 00:00:00